Kiromic BioPharma Statistics
Total Valuation
KRBPQ has a market cap or net worth of 157. The enterprise value is 13.43 million.
| Market Cap | 157 |
| Enterprise Value | 13.43M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
KRBPQ has 1.57 million shares outstanding. The number of shares has increased by 33.09% in one year.
| Current Share Class | 1.57M |
| Shares Outstanding | 1.57M |
| Shares Change (YoY) | +33.09% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 22.35% |
| Owned by Institutions (%) | n/a |
| Float | 1.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.90 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.68 |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.73 |
| Interest Coverage | -6.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -143.47% |
| Return on Invested Capital (ROIC) | -353.65% |
| Return on Capital Employed (ROCE) | 192.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -105,136 |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.99% in the last 52 weeks. The beta is 2.12, so KRBPQ's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 36.86 |
| Average Volume (20 Days) | 7,038 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.77M |
| Pretax Income | -26.90M |
| Net Income | -4.63M |
| EBITDA | -21.54M |
| EBIT | -23.77M |
| Earnings Per Share (EPS) | -3.17 |
Balance Sheet
The company has 1.14 million in cash and 14.57 million in debt, giving a net cash position of -13.43 million or -8.55 per share.
| Cash & Cash Equivalents | 1.14M |
| Total Debt | 14.57M |
| Net Cash | -13.43M |
| Net Cash Per Share | -8.55 |
| Equity (Book Value) | -12.59M |
| Book Value Per Share | -8.21 |
| Working Capital | -17.60M |
Cash Flow
In the last 12 months, operating cash flow was -19.46 million and capital expenditures -366,000, giving a free cash flow of -19.82 million.
| Operating Cash Flow | -19.46M |
| Capital Expenditures | -366,000 |
| Free Cash Flow | -19.82M |
| FCF Per Share | -12.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KRBPQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.09% |
| Shareholder Yield | -33.09% |
| Earnings Yield | -2,946,496.82% |
| FCF Yield | -12,626,751.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 13, 2023. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Mar 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |